MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$3,284K
Interest and other income
$3,052K
Change in fair value of
warrants
-$670K
Clinical treatment
programs - us
$26K
Loss on issuance of
warrants
-$3,977K
Operating loss
-$2,447K
Total revenues
$26K
Issuance cost
$433K
Interest expense and
other finance costs
$148K
Gain (loss) on
investments
-$1K
Total costs and
expenses
$2,473K
General and
administrative
$1,798K
Research and development
$607K
Production costs
$68K
Back
Back
Income Statement
source: myfinsight.com
AIM ImmunoTech Inc. (AIMI)
AIM ImmunoTech Inc. (AIMI)